Document Detail


Tolerability of doxofylline in the maintenance therapy of pediatric patients with bronchial asthma.
MedLine Citation:
PMID:  11261736     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A retrospective open study was performed to ascertain the tolerability of doxofylline in pediatric patients with bronchial asthma or airway obstruction complicating acute bronchitis. The study population included 806 patients aged between 3 and 16 years. Doxofylline (200 mg sachets) was administered at daily doses ranging from 100 to 400 mg. The percentage of patients reporting side effects was 11%. The percent of patients reporting moderate side effect was 5%, the others being mild. The percent of patients reporting adverse event very likely due to doxofylline was 6%. The percent of patient drop-outs related to side effects was 5%.
Authors:
G F Bagnato
Related Documents :
17764476 - Effect of theophylline on the rate of moderate to severe exacerbations among patients w...
16236836 - Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis: comparis...
17042136 - Profiles of proinflammatory cytokines in sputum from different groups of severe asthmat...
20207926 - An evaluation of peak expiratory flow monitoring: a comparison of sitting versus standi...
8348076 - Six colombian patients with adult t-cell leukemia/lymphoma.
23073796 - Assessment of nutritional status of clinical patients by determining normal range of or...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European review for medical and pharmacological sciences     Volume:  3     ISSN:  1128-3602     ISO Abbreviation:  Eur Rev Med Pharmacol Sci     Publication Date:    1999 Nov-Dec
Date Detail:
Created Date:  2001-03-22     Completed Date:  2001-06-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9717360     Medline TA:  Eur Rev Med Pharmacol Sci     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  255-60     Citation Subset:  IM    
Affiliation:
Dipartimento di Medicina Interna e Terapia Medica, Università degli Studi di Messina, Italia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Anti-Asthmatic Agents / adverse effects*,  therapeutic use*
Asthma / drug therapy*
Child
Child, Preschool
Female
Humans
Male
Retrospective Studies
Theophylline / adverse effects*,  analogs & derivatives*,  therapeutic use*
Chemical
Reg. No./Substance:
0/Anti-Asthmatic Agents; 58-55-9/Theophylline; 69975-86-6/doxofylline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  State of the art and new perspectives on dry powder inhalers.
Next Document:  A multidisciplinary approach to the treatment of small-cell lung cancer: the role played by surgery.